4Janka GE.Familial and acquired hemophagocytic lymphohistiocytosis[J].Annu Rev Med,2012,63:233-246.
5Rosado FG,Kim AS.Hemophagocytic lymphohistiocytosis:an update on diagnosis and pathogenesis[J].Am J Clin Pathol,2013,139(6):713-727.
6Zhizhuo H,Junmei X,Yuelin S,et al.Screening the PRFl,UNCl3D,STXll,SHZDl A,XIAP,and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis[J].Pediatr Blood Cancer,2012,58(3):410-414.
7Chuang HC,Wang JM,Hsieh WC,et al.Up-regulation of activating transcription factor-5 suppresses SAP expression to activate T cells in hemophagocytic syndrome associated with Epstein-Barr virus infection and immune disorders[J].Am J Pathol,2008,173(5):1397-1405.
8Henter JI,Horne A,Arico M,et al.HLH-2004:Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J].Pediatr Blood Cancer,2007,48(2):124-131.
9Al Asad O,Salam A,Mannem S,et al.Alternative therapy for epstein-barr virus related hemophagocytic lymphohistiocytosis[J].Case Rep Oncol Med,2015,2015:508387.
10Xue H,Chen C,Li W,et al.Analysis of prognostic risk factors in children with Epstein-Barr virus-associated hemophagocytic syndrome[J].Minerva Pediatr,2015,67(3):251-261.
